drug product / pharmaceutical / treatment of smallpox / health product / laboratory network / gene synthesis technology / /
MedicalCondition
variola infections / further animal model research using variola / variola virus research / eradicated disease / variola / smallpox research programme / smallpox research program / Smallpox / variola virus infection / live variola virus / truly eradicating smallpox / additional variola virus / variola researchers / variola stocks / actual variola virus / human infection / advanced illness / monkeypox infection / variola scientists / human smallpox / eczema vaccinatum / then variola virus / disseminated infection / Variola minor / variola virus infections / Both candidate smallpox / smallpox infection / influenza / variola research / variola strains / variola virus destruction / live variola / human variola virus infection / variola virus / disease / smallpox disease / Ebola / monkeypox / smallpox virus / generation smallpox / synthetic variola virus / variola virus stocks / human smallpox disease / vaccinia virus / vaccinia / efficacy using live variola / variola synthetic biology risks / alastrim / /
MedicalTreatment
vaccination / /
Organization
World Health Organization / ACVVR / US Department of Defense / 64th World Health Assembly / US Food and Drug Administration / Third World Network / / /
Position
model research involving / General / misbehaving scientist / lab technician / Animal Model For years / model research using variola / Major / /
Product
CMX001 / /
PublishedMedium
the Scientific Review / /
RadioStation
WHA / /
Technology
genetic engineering / diagnostic tests / developing gene synthesis technology / drug development / /
TWN Briefing Paper Third World Network